Stay updated with breaking news from Syneos health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CET finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.
In a subdued year for global M&A, deal-making in the life sciences industry came in waves, with a busy fourth quarter generating cautious optimism heading into 2024.
In a subdued year for global M&A, deal-making in the life sciences industry came in waves, with a busy fourth quarter generating cautious optimism heading into 2024. While the year saw...
/PRNewswire/ -- The "Pharma Clinical Trial Services Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering. Pharma Clinical Trial...
Strasbourg, France, January 22, 2024, 5:45 p.m. CET – Transgene , a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased to announce the...
Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
Strasbourg, France, January 22, 2024, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased to announce the appointment of James Wentworth, PhD, MBA, as Chief Business Officer (CBO) and member of the executive management team, effective immediately. Dr. Wentworth will be responsible for developing, leading, and implementing Transgene’s business, corporate development and partnering strategi